BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27051668)

  • 1. Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.
    Ramos PK; Carvalho KI; Rosa DS; Rodrigues AP; Lima LV; Campos MB; Gomes CM; Laurenti MD; Corbett CE; Silveira FT
    Biomed Res Int; 2016; 2016():6937980. PubMed ID: 27051668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study on the clinical and immunological spectrum of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region.
    Crescente JA; Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1250-6. PubMed ID: 19615710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study on the dynamics of the clinical and immunological evolution of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region.
    Silveira FT; Lainson R; Crescente JA; de Souza AA; Campos MB; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2010 Aug; 104(8):529-35. PubMed ID: 20538310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine qPCR diagnoses over the entire clinical-immunological spectrum of human Leishmania (L.) infantum chagasi-infections in the Brazilian Amazon.
    Ramos PKS; Gonçalves LP; Alves ACO; Casseb SM; Lima LVDR; Campos MB; Vasconcelos Dos Santos T; Silveira FT
    Parasitol Int; 2021 Apr; 81():102273. PubMed ID: 33333246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.
    do Rêgo Lima LV; Santos Ramos PK; Campos MB; dos Santos TV; de Castro Gomes CM; Laurenti MD; Corbett CE; Silveira FT
    Pathog Glob Health; 2014 Dec; 108(8):381-4. PubMed ID: 25491437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.
    Silveira FT; Lainson R; De Souza AA; Campos MB; Carneiro LA; Lima LV; Ramos PK; de Castro Gomes CM; Laurenti MD; Corbett CE
    Parasitol Res; 2010 Jan; 106(2):377-86. PubMed ID: 19946708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control.
    Lima L; Vasconcelos-Dos-Santos T; Campos M; Ramos PK; Gomes C; Laurenti M; da Matta V; Corbett C; Silveira F
    Parasite Epidemiol Control; 2020 Aug; 10():e00154. PubMed ID: 32435706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.
    Silveira FT; Carneiro LA; Ramos PK; Chagas EJ; Lima LV; Campos MB; Laurenti MD; Gomes CM; Corbett CE
    Parasitol Res; 2012 Oct; 111(4):1513-22. PubMed ID: 22706905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Signatures of Symptomatic and Asymptomatic Clinical-Immunological Profiles of Human Infection by
    da Matta VLR; Gonçalves AN; Gomes CMC; Chouman IH; Ferreira FM; Campos MB; Lima LV; Vasconcelos Dos Santos T; Ramos PK; Furtado RR; Laurenti MD; Corbett CEP; Nakaya HI; Silveira FT
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence.
    Silveira FT; Lainson R; Pereira EA; de Souza AA; Campos MB; Chagas EJ; Gomes CM; Laurenti MD; Corbett CE
    Parasitol Res; 2009 Feb; 104(3):559-67. PubMed ID: 18936975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral Leishmaniasis Urbanization in the Brazilian Amazon Is Supported by Significantly Higher Infection Transmission Rates Than in Rural Area.
    Furtado RR; Alves AC; Lima LVR; Vasconcelos Dos Santos T; Campos MB; Ramos PKS; Gomes CMC; Laurenti MD; da Matta VL; Corbett CE; Silveira FT
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36363780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospection of immunological biomarkers for characterization and monitoring of asymptomatic
    da Cunha GMR; Carneiro M; Pascoal-Xavier MA; da Rocha ICM; Magalhães FDC; Martins-Filho OA; Oliveira E; Peruhype-Magalhães V
    Parasitology; 2020 Sep; 147(10):1124-1132. PubMed ID: 32460936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi.
    Stober CB; Jeronimo SM; Pontes NN; Miller EN; Blackwell JM
    Am J Trop Med Hyg; 2012 Oct; 87(4):663-70. PubMed ID: 22826477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human asymptomatic infection in visceral leishmaniasis: a seroprevalence study in an urban area of low endemicity. Preliminary results.
    Barão SC; de Fonseca Camargo-Neves VL; Resende MR; da Silva LJ
    Am J Trop Med Hyg; 2007 Dec; 77(6):1051-3. PubMed ID: 18165520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis.
    D'Oliveira Júnior A; Costa SR; Barbosa AB; Orge M de la G; Carvalho EM
    Mem Inst Oswaldo Cruz; 1997; 92(1):15-20. PubMed ID: 9302407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Van Weyenbergh J; Correa-Oliveira R
    Clin Exp Immunol; 2006 Oct; 146(1):124-32. PubMed ID: 16968407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.
    Dos Santos PL; de Oliveira FA; Santos ML; Cunha LC; Lino MT; de Oliveira MF; Bomfim MO; Silva AM; de Moura TR; de Jesus AR; Duthie MS; Reed SG; de Almeida RP
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004375. PubMed ID: 26814478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.
    Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS
    J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.